# reload+after+2024-01-20 03:46:48.050712
address1§99 Hayden Avenue
address2§Suite 390
city§Lexington
state§MA
zip§02421
country§United States
phone§781 357 2333
website§https://www.pulmatrix.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; and a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of PUR1900. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
fullTimeEmployees§28
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Teofilo David Raad MBA', 'age': 53, 'title': 'President, CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 772697, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Peter  Ludlum CMA, MBA', 'age': 68, 'title': 'Interim CFO and Principal Accounting & Financial Officer', 'yearBorn': 1955, 'fiscalYear': 2022, 'totalPay': 398583, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Margaret M. Wasilewski M.D.', 'age': 66, 'title': 'Chief Medical Officer', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 585840, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Alexander M. Klibanov Ph.D.', 'age': 73, 'title': 'Founder', 'yearBorn': 1950, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.693
priceToSalesTrailing12Months§1.1004077
currency§USD
dateShortInterest§1702598400
forwardEps§-4.5
exchange§NCM
quoteType§EQUITY
shortName§Pulmatrix, Inc.
longName§Pulmatrix, Inc.
firstTradeDateEpochUtc§1395408600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ce557c10-826b-3ca1-9c92-465f072de0d9
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§5.007
grossMargins§-1.4204899
ebitdaMargins§-2.45517
trailingPegRatio§None
